Activist 13D/13G Filings - Lexaria Bioscience Corp. (LEXX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-11-14
4:11 pm
Sale
13GLexaria Bioscience Corp.
LEXX
Invenomic Capital Management LP567,650
4.700%
-164,331decrease
(-22.45%)
View
2024-09-23
1:28 pm
Sale
13DLexaria Bioscience Corp.
LEXX
Boos Wayne W600,000
3.795%
-315,425decrease
(-34.46%)
View
2024-08-06
4:11 pm
Sale
13DLexaria Bioscience Corp.
LEXX
Boos Wayne W915,425
5.790%
-104,575decrease
(-10.25%)
View
2024-04-25
4:57 pm
Purchase
13DLexaria Bioscience Corp.
LEXX
Boos Wayne W1,020,000
8.050%
540,000increase
(+112.50%)
View
2024-02-14
2:20 pm
Purchase
13DLexaria Bioscience Corp.
LEXX
Boos Wayne W480,000
4.671%
30,000increase
(+6.67%)
View
2024-02-14
12:00 pm
Purchase
13GLexaria Bioscience Corp.
LEXX
Invenomic Capital Management LP731,981
7.120%
258,878increase
(+54.72%)
View
2023-09-18
10:42 am
Purchase
13DLexaria Bioscience Corp.
LEXX
Boos Wayne W450,000
5.561%
450,000increase
(New Position)
View
2023-02-10
4:06 pm
Purchase
13GLexaria Bioscience Corp.
LEXX
Invenomic Capital Management LP473,103
7.950%
113,990increase
(+31.74%)
View
2022-02-11
5:49 pm
Sale
13GLexaria Bioscience Corp.
LEXX
L1 Capital Global Opportunities Master Fund Ltd.159,000
2.600%
-126,714decrease
(-44.35%)
View
2022-02-11
5:33 pm
Purchase
13GLexaria Bioscience Corp.
LEXX
Invenomic Capital Management LP359,113
6.030%
359,113increase
(New Position)
View
2021-02-23
9:04 pm
Purchase
13DLexaria Bioscience Corp.
LEXX
BUNKA CHRISTOPHER489,455
9.500%
489,455increase
(New Position)
View
2021-01-20
4:05 pm
Purchase
13GLexaria Bioscience Corp.
LEXX
L1 Capital Global Opportunities Master Fund Ltd.285,714
5.600%
285,714increase
(New Position)
View